Osteonecrosis of the Jaw News and Research

RSS
Six-year data of reinforces efficacy and safety of Reclast injection in postmenopausal women with osteoporosis

Six-year data of reinforces efficacy and safety of Reclast injection in postmenopausal women with osteoporosis

BCF publishes two new patient publications

BCF publishes two new patient publications

Phase 3 trial demonstrates superiority of Amgen's denosumab over Zometa in preventing SREs

Phase 3 trial demonstrates superiority of Amgen's denosumab over Zometa in preventing SREs

Positive results from new analyses of denosumab Phase 3 trials

Positive results from new analyses of denosumab Phase 3 trials

FDA approves Prolia for postmenopausal women with osteoporosis

FDA approves Prolia for postmenopausal women with osteoporosis

Use of bisphosphonates associated with risk of developing BON after dental surgery: Study

Use of bisphosphonates associated with risk of developing BON after dental surgery: Study

Denosumab exhibits superiority over Zometa in treatment of prostate cancer men with bone metastases

Denosumab exhibits superiority over Zometa in treatment of prostate cancer men with bone metastases

New data suggests bisphosphonate drug may play a role in reducing recurrent breast cancer

New data suggests bisphosphonate drug may play a role in reducing recurrent breast cancer

U.S. Court rules in Merck's favor in Flemings case involving FOSAMAX

U.S. Court rules in Merck's favor in Flemings case involving FOSAMAX

Amgen announces results of Phase 3 head-to-head trial evaluating denosumab versus Zometa

Amgen announces results of Phase 3 head-to-head trial evaluating denosumab versus Zometa

Amgen announces results of Phase 3 trial in the treatment of bone metastases

Amgen announces results of Phase 3 trial in the treatment of bone metastases

Denosumab reduces fracture risk in men receiving androgen-deprivation therapy for prostate cancer

Denosumab reduces fracture risk in men receiving androgen-deprivation therapy for prostate cancer

Childhood Varicella zoster could affect oral health years later

Childhood Varicella zoster could affect oral health years later

Oral bisphosphonates linked to increased jaw necrosis

Oral bisphosphonates linked to increased jaw necrosis

Zometa (zoledronic acid) shown to enhance chemotherapy in reducing breast tumor size

Zometa (zoledronic acid) shown to enhance chemotherapy in reducing breast tumor size

Osteonecrosis of the jawbone and oral bisphosphonates

Osteonecrosis of the jawbone and oral bisphosphonates

Oral post-surgical complications following the administration of bisphosphonates given for osteopenia related to malignancy

Oral post-surgical complications following the administration of bisphosphonates given for osteopenia related to malignancy

Link found between bisphosphonates and a serious bone disease called osteonecrosis of the jaw

Link found between bisphosphonates and a serious bone disease called osteonecrosis of the jaw